Accessibility Menu
 
Isodiol International logo

Isodiol International

(OTC) ISOLF

Current Price$0.00
Market CapN/A
Since IPO (2017)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Isodiol International Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$11.92K

Net Income (TTM)

$73.39K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-17.73 (Low)

Price

$0.00

Volume

19,564

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

ISOLF News

No articles available.

ISOLF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Isodiol International

Industry

Pharmaceuticals

Headquarters

Vancouver, BC V6C 1S4, CA

ISOLF Financials

Key Financial Metrics (TTM)

Gross Margin

-24%

Operating Margin

-2%

Net Income Margin

-5%

Return on Equity

0%

Return on Capital

-3%

Return on Assets

-5%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

0

Volume

19.56K

Short Interest

0.00%

Avg. Volume

469.902

Financials (TTM)

Gross Profit

$4.05M

Operating Income

$29.23M

EBITDA

$84.50M

Operating Cash Flow

$17.99M

Capital Expenditure

$3.35M

Free Cash Flow

$21.34M

Cash & ST Invst.

$2.15M

Total Debt

$6.06M

Isodiol International Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2019YOY CHG

Revenue

$1.02K

-85.0%

Gross Profit

$377.00

-87.5%

Gross Margin

36.96%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$747.04

+95.3%

EBITDA

$622.18K

+95.0%

Quarterly Fundamentals

Name
Q3 2019YOY CHG

Net Cash

$3.21K

+23.8%

Accounts Receivable

$1.68M

-57.4%

Inventory

$1.97K

-60.7%

Long Term Debt

$5.68M

+146247.9%

Short Term Debt

$169.81K

+7737.4%

Return on Assets

-5.11%

N/A

Return on Invested Capital

-3.22%

N/A

Free Cash Flow

$180.32

+102.3%

Operating Cash Flow

$180.32

+102.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OWCPOWC Pharmaceutical Research Corp.
$0.00+0.00%
ATTBFAbattis Bioceuticals Corp.
$0.00+0.00%
INSDInstadose Pharma Corp.
$0.00+0.00%
NUNZNunzia Pharmaceutical Company
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
RITMRithm Capital
$8.77-0.03%

Questions About ISOLF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.